+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital



Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital



Journal of Pharmacology and Pharmacotherapeutics 3(4): 308-313



To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact. This was a prospective study carried out in two medical units at a tertiary care, teaching hospital, for about 18 months. All the admitted patients who developed an ADR after admission (group A) or who were admitted primarily for the treatment of an ADR (group B) were included. Descriptive statistics with 95% CI, χ(2), χ(2) for the trend and kappa test were used. Out of 6601 patients, 140 patients developed 154 ADRs with an incidence of 2.12%. Causality of the majority of the ADRs in group A was 'possible' while those in group B was 'probable'. Among 109 ADRs (34 serious) in group A, 38 were preventable. On the other hand, out of 45 serious ADRs in group B, 19 were preventable. The total cost of 154 ADRs in 140 patients was Rs. 1,49,803 with an average of Rs. 1070 per patient. The preventable cost for 57/154 ADR was Rs. 96,310. Around 2% of the hospital patients develop ADRs. A large number of these ADRs were preventable. A substantial saving can be made if adequate caution is exerted.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053899956

Download citation: RISBibTeXText

PMID: 23326101

DOI: 10.4103/0976-500x.103687


Related references

Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study. Indian Journal of Dermatology 62(6): 618-625, 2017

Reporting Adverse Drug Reactions Among Hospitalized Medical Patients: A Prospective Study From Tertiary Care Hospital in Western Nepal. Nepal Journal of Epidemiology 4(1): 330-336, 2014

Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiology and Drug Safety 18(7): 639-645, 2009

Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series. Indian Journal of Critical Care Medicine 18(5): 315-319, 2014

Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Medicine 33(12): 2150-2157, 2007

Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal. Pakistan Journal of Pharmaceutical Sciences 21(1): 51-56, 2008

Adverse drug reactions in neonates hospitalized in neonatal intensive care units in Barranquilla, Colombia. Biomedica 37(0): 33-42, 2017

An analysis of serious adverse drug reactions at a tertiary care teaching hospital. Perspectives in Clinical Research 7(4): 181-186, 2016

Adverse drug reaction monitoring in a tertiary care teaching hospital. Journal of Pharmacology and Pharmacotherapeutics 2(3): 196-198, 2011

Evaluation of adverse drug reactions in medical intensive care units. European Journal of Clinical Pharmacology 69(1): 119-131, 2013

Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital. Therapeutic Advances in Drug Safety 8(2): 61-66, 2017

Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital. Journal of Pharmacology and Pharmacotherapeutics 3(3): 242-247, 2012

Adverse drug reactions reporting by undergraduate medical students in a tertiary care teaching hospital of India: Content and quality analysis in comparison to physician reporting. Perspectives in Clinical Research 8(3): 137-144, 2017

An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital. Perspectives in Clinical Research 9(2): 70-75, 2018

Cost of adverse drug reactions in a South Indian tertiary care teaching hospital. Journal of Clinical Pharmacology 52(4): 559-565, 2012